Sign In   |   Register
EAS Advanced Course on Precision Medicine in Atherosclerosis, Paris - Prel. Scientific Programme
Share |
Thursday, October 05, 2017 
 19:00-22:00  Networking dinner  
Friday, October 06, 2017 
Session 1: Morning Novel Diagnostics towards improved patient
stratification and targeted therapy
08:30 Welcome: Introduction and Objectives Eric Bruckert
08:40 Precision Cardiovascular Medicine: an unmet need or just a fashion? Eran Leitersdorf
09:00 Human Genetics from validation of novel cardiovascular drug targets to molecular diagnosis Alain Carrié
09:45 Do Novel Biomarkers improve cardiovascular risk stratification? Arnold Von Eckardstein
10:30 Break
11:00 Is there a role for Advanced Atherosclerosis Imaging in targeted cardiovascular therapy? TBC
11:45 Nutrigenomics for prevention and treatment of obesity Judith Aron-Wisnewsky
12:15 How is the Pharmaceutical Industry preparing for the new era of Precision Cardiovascular Medicine? Fouzia Laghrissi
13:00 Lunch break  
Session 2: Afternoon Therapeutic considerations based on the
genetic background and disease phenotypes
14:00 Identification of novel targets in Hypertension and priorities for drug development David Rosenbaum
14:45 Can we refine strategy on HDL by new pharmacological approaches? John Chapman
15:30 Will precision medicine help tailor dyslipidemia treatment? TBC
16:15 Panel Discussion - All speakers  led by Eric Bruckert
16:20 Concluding Remarks Eric Bruckert
16:30 Departures
Membership Software Powered by YourMembership  ::  Legal